DrugPatentWatch Database Preview
Drugs in MeSH Category Vasoconstrictor Agents
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-001 | Aug 10, 2012 | BX | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||
| Genus Lifesciences | GOPRELTO | cocaine hydrochloride | SOLUTION;NASAL | 209963-001 | Dec 14, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-002 | Aug 10, 2012 | BX | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||
| Fresenius Kabi Usa | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210666-001 | Jan 30, 2019 | AP1 | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Unique Pharm Labs | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 207613-003 | Nov 2, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Meitheal | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210334-001 | Apr 27, 2018 | AP2 | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
